BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  Common Pesticide May Increase Risk Of ADHD, Rutgers, The State University Of New Jersey Study

  February 2, 2015

   · 

  3 min read
• 

  Business

  Mylan, Theravance Biopharma Partner Up for $265 Million COPD Pact

  February 2, 2015

   · 

  2 min read
• ELC GROUP To Present At “Regulatory & Legal Affairs In Russia 2015" Conference

  February 2, 2015

   · 

  3 min read
• Business

  Medtronic, Inc. Strikes a Huge Home Health Care Partnership Deal

  February 2, 2015

   · 

  3 min read
• Drug Development

  bluebird bio Release: FDA Grants Breakthrough Therapy Designation To Lentiglobin For Treatment Of Beta-Thalassemia Major

  February 2, 2015

   · 

  7 min read
• Deals

  ICON Snaps Up MediMedia Pharma Solutions for $120 MIllion Cash

  February 2, 2015

   · 

  5 min read
• Drug Development

  Treatment Of The First HIV Positive Patient In ABIVAX’s Phase 2a Clinical Trial With ABX464

  February 2, 2015

   · 

  5 min read
• FDA

  CytoSorbents, Inc. Announces FDA Approval To Commence Initial U.S. Cardiac Surgery Study

  February 2, 2015

   · 

  6 min read
• FDA

  Shire Release: Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First And Only Treatment Approved By The FDA For Adults With Moderate To Severe Binge Eating Disorder

  February 2, 2015

   · 

  12 min read
• Business

  Helsinn Group Grants Stendhal International Exclusive Rights To The Distribution And Marketing Of Netupitant-Palonosetron (NEPA) In Multiple Countries Of Latin America

  February 2, 2015

   · 

  5 min read